A century of progress. From biology to antithrombotic drugs;Un siècle de progrès: De la biologie aux médicaments anti-thrombotiques

Journal des Maladies Vasculaires

Volumn 26, Issue 3, 2001, Pages 165-168

  Samama, M M ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TICLOPIDINE;

CHROMOSOME 17; CONFERENCE PAPER; DRUG EFFICACY; DRUG USE; GENE MUTATION; HEREDITY; HUMAN; PROPHYLAXIS; THROMBOEMBOLISM; THROMBOSIS;

4-HYDROXYCOUMARINS; ANTICOAGULANTS; BIOLOGY; CLINICAL TRIALS; FIBRINOLYTIC AGENTS; HEPARIN; HISTORY, 20TH CENTURY; HUMANS; INDENES; VITAMIN K;

EID: 0034931002     PISSN: 03980499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (28)

1. Cholesterinstoffwechsel in Hünereiern und Hünchen
2. The antihaemorrhagic vitamin of the chick. Occurrence and chemical nature
3. The discovery of Dicumarol and its sequels
4. A study of the coagulation defect in hemophilia and jaundice
5. The discovery of heparin
6. The nature and action of the thromboplastin (zymoplastic) substance of the tissues
7. Theories of blood coagulation
8. Anticoagulant therapy in surgery
9. The possible indication of postoperative thromboembolism by platelet counts and blood coagulation studies in the patient undergoing extensive surgery
10. Prevention of fatal pulmonary embolism by low doses of heparin
11. Four heparin preparations: Anti-Xa potentiating effect of heparin after subcutaneous injection
12. Effects of heparin oligosaccharides with high affinit for antithrombin III in experimental venous thrombosis
13. The molecular weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin. Factor Xa, Factor IXa, factor XIa, factor XIIa and kallicrein by antithrombin
14. Unfractionated heparin, low molecular weight heparins and heparinoid in orthopedic and trauma surgery
15. Efficacy and safety of low molecular weight heparins in the prevention of venous thromboembolism in general surgery
16. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients
17. Hereditäre hämorragische Thrombasthenie. Ein Beitrag zur Pathologie der Blutplättchen
18. Platelet adhesiveness
19. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets
20. An abnormal glycoprotein pattern in 3 cases of Glanzmann thrombasthenia
21. Platelet vessel wall interaction: From the bedside to molecules
22. The molecular genetic basis of Glanzmann's thrombasthenia in a Gyspsy population in France: Identification of a new mutation on the alpha Hb gene
23. Glanzmann thrombasthenia: New insights from an historical perspective
24. Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy
25. Combined thrombolytic and platelet glycoprotein IIb/IIIa inhibitor therapy for acute myocardial infarction. Will pharmacological therapy ever equal primary angioplasty?
26. Difficulties with oral platelet glycoprotein Iib/IIIa receptor antagonist